 |
|
Inhaled iloprost for the treatment of patient with Fontan circulation
Yong Hyun Kim (Kim YH), Moon Hee Chae (Chae MH), Deok Young Choi (Choi DY)
Clin Exp Pediatr. 2014;57(10):461-463. Published online 2014 Oct 31 DOI: https://doi.org/10.3345/kjp.2014.57.10.461
|
|
Citations to this article as recorded by
 Medical Therapies for Heart Failure in Hypoplastic Left Heart Syndrome
Angela N. Baybayon-Grandgeorge, Ashley E. Pietra, Shelley D. Miyamoto, Anastacia M. Garcia
Journal of Cardiovascular Development and Disease.2022; 9(5): 152. CrossRef Heart failure in single right ventricle congenital heart disease: physiological and molecular considerations
Anastacia M. Garcia, Jonathan-Thomas Beatty, Stephanie J. Nakano
American Journal of Physiology-Heart and Circulato.2020; 318(4): H947. CrossRef Focused Update on Pulmonary Hypertension in Children—Selected Topics of Interest for the Adult Cardiologist
Sulaima Albinni, Manfred Marx, Irene M. Lang
Medicina.2020; 56(9): 420. CrossRef After planned surgeries, there is still work to be done: Medical therapies
David M. Finkelstein, David J. Goldberg
Progress in Pediatric Cardiology.2019; 54: 101133. CrossRef The use of Macitentan in Fontan circulation: a case report
Polyvios Demetriades, Amir Aziz, Robin Condliffe, Sarah E. Bowater, Paul F. Clift
BMC Cardiovascular Disorders.2017;[Epub] CrossRef Managing adult Fontan patients: where do we stand?
Paul Clift, David Celermajer
European Respiratory Review.2016; 25(142): 438. CrossRef
|